FFAR2 and fatty liver disease: Mechanistically, our data suggest that PPA-induced hepatoprotection is associated with the activation of the GPR43–Ca2+–CaMKII–ATGL signalling cascade, promoting intracellular lipolysis and attenuating hepatic steatosis.